UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Pharmaceuticals shifting from traditional to digital sales marketing: IQVIA
by Marian Chu
2018-07-03 17:44
Platform technologies key to developing new drugs
by So Jae-hyeon
2018-07-03 16:12
MSD Korea fails to submit PMS data, gets Elonva approval canceled
by Marian Chu
2018-07-03 16:11
SillaJen to develop biomarker for JX-970
by So Jae-hyeon
2018-07-03 14:19
Ministry approves CJ Healthcare’s CINV treatment
by Lee Han-soo
2018-07-03 12:47
라인
Alexion Pharma Korea’s aHUS therapy Soliris gains coverage
by Marian Chu
2018-07-02 17:02
Takeda’s diabetes therapy to see 10 generics soon
by Marian Chu
2018-07-02 17:01
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’
by Nam Doo-hyun
2018-07-02 16:47
SK Bioscience starts business
by Lee Han-soo
2018-07-02 15:00
Sanofi Korea presents findings on head-to-head trial on Toujeo vs. Tresiba
by Marian Chu
2018-06-29 18:01
라인
VUNO unveils SW with excellent function for predicting cardiac arrest
by Marian Chu
2018-06-29 17:29
Eisai’s Aricept dominates dementia treatment market
by So Jae-hyeon
2018-06-29 15:24
BMS Korea wins fight for Eliquis patent
by Nam Doo-hyun
2018-06-29 14:41
Botulinum toxin makers compete to expand indications
by So Jae-hyeon
2018-06-29 14:07
Korean pharmaceuticals fail to invalidate Invokana patent
by Marian Chu
2018-06-28 17:58
라인
Pfizer’s kidney cancer therapy Inlyta to be reimbursed in July
by Lee Hye-seon
2018-06-28 17:57
Weight-loss drug Saxenda creates marketing sensation in Korea
by Lee Hye-seon
2018-06-28 16:40
Hugel, Hamni to cooperate in urology market
by Lee Han-soo
2018-06-28 16:39
Herbalife Korea publishes results of genetic big data analysis
by Marian Chu
2018-06-28 14:52
Hepatitis B reactivation added to Simulect precautions
by Lee Hye-seon
2018-06-28 12:20
-
이전
71
72
73
74
75
76
77
78
79
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top